Ticker: VKTX

Company: Viking Therapeutics, Inc.

Person: GREG ZANTE, officer

Transaction date: Oct. 27, 2025

Reporting date: Oct. 28, 2025

Average share price: -43.89305890105434

Sold 4932.0 shares for 216480.57